Stage IB Breast Cancer Recruiting Phase 2 Trials for Cyclophosphamide (DB00531)

IndicationStatusPhase
DBCOND0029218 (Stage IB Breast Cancer)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03012100Multi-epitope Folate Receptor Alpha Peptide Vaccine, Sargramostim, and Cyclophosphamide in Treating Patients With Triple Negative Breast CancerTreatment